Skip to the sheet
GLP1Rx workbook

Coverage, cash pay, and the path from a visit to a filled prescription.

Workbook sheet

Telehealth, a clinic, or a specialist

GLP1Rx.org editorial team. Published November 18, 2026. Last reviewed November 18, 2026.

The visit can be in an exam room, on a video call, or split between a primary-care office and an obesity clinic. The drug label does not prefer a floor plan. It does require a prescriber who can decide whether an indication fits and whether a contraindication rules the drug out. NIDDK describes weight-management medicines as additions to lifestyle treatment, not replacements for it. Yale Medicine’s getting-started explainer and UT Southwestern’s patient FAQ both frame the first conversation as a medical one: history, risks, and a plan that still includes food and activity. This sheet is about how to compare the settings. Getting GLP-1 online is the consumer version of the remote visit. People who want a directory of program models can look at online GLP-1 programs and then verify the clinician themselves. A directory is not a credential.

What every setting owes you

Identity and location. Prescribing follows state law. A video visit with a clinician not licensed where you are sitting is a problem even if the website looks national.

A history that can support or reject the label. For Wegovy and Zepbound that includes the boxed-warning questions: personal or family history of medullary thyroid carcinoma, and MEN 2. It includes pregnancy plans. Wegovy’s label says to stop at least two months before a planned pregnancy for the weight and cardiovascular uses, and to discontinue when pregnancy is recognized. It includes other medicines, because both labels say not to combine GLP-1 receptor agonists, and because insulin and sulfonylureas raise hypoglycemia risk. It includes pancreas, gallbladder, kidney, and, if you have diabetes, eye history, because those are warning sections.

A named product and a starting dose that matches the label. Wegovy injection starts at 0.25 mg weekly. Zepbound starts at 2.5 mg weekly, and that dose is not maintenance. A program that ships a maintenance strength first is not following the escalation the labels use to limit gastrointestinal adverse reactions.

A follow-up plan. Escalation is supposed to consider tolerability. Someone has to hear that you vomited for three days. A refill robot is not that someone.

A dispensing plan you can describe. FDA-approved pen, FDA-approved tablet, or compounded product. FDA has warned telehealth companies about marketing that implies compounded GLP-1 drugs are the same as approved drugs or are generics. Ask the plain question. If coverage is denied is a different problem from being switched to a compounded vial you did not intend.

Primary care, specialist, and the video visit

Primary care is often the right first stop because that clinician already has your blood pressure, your diabetes medicines, and your pregnancy plans. The limit is time and, in some offices, a policy not to prescribe weight-management GLP-1 drugs. A refusal can be clinical. It can also be a practice decision. Ask which one it is. If it is clinical, you should leave with the reason, especially if it is a contraindication you will need to repeat elsewhere.

An obesity-medicine or endocrine clinic is useful when the history is complicated: prior bariatric surgery, multiple weight-loss drugs, severe gastrointestinal disease, or a plateau on a carefully escalated dose. The visit is still history, exam as needed, and a prescription. It is not automatically more legitimate than a careful primary-care visit. It is sometimes the place that has more time.

A telehealth visit can do the history, order labs, and send a prescription to a pharmacy. It is weaker when a physical finding would change the plan and nobody arranges an in-person exam. It is inappropriate when the model hides the clinician’s name. It is a reasonable option when you cannot get an appointment locally and the service meets the list above. https://www.surpassmd.com/ is one telehealth practice that evaluates people for GLP-1 weight-loss care. Use the same checklist there. The fact that this workbook mentions it is a disclosure of a network relationship, not a ranking against your own clinician.

Labs and monitoring, without a fake panel

No label says “order this exact blood panel or do not prescribe.” Clinicians commonly want enough information to handle the warnings they are about to accept: kidney function if dehydration would be dangerous, glucose measures if diabetes or insulin is in play, and a documented weight and blood pressure because those are the conditions being treated. Pregnancy testing when pregnancy is possible is ordinary medicine, not a GLP-1 quirk. Ask what your clinician wants before the first dose and who will read the result. A membership that advertises “labs included” should name the tests. A membership that says labs are unnecessary for everyone is making a blanket clinical claim the label does not make.

After you start, monitoring is symptom-driven and schedule-driven. Report severe abdominal pain, persistent vomiting, signs of dehydration, allergic reactions, and low-glucose symptoms if you use insulin or a sulfonylurea. Planned follow-up is where the dose steps. Tell a surgical team you are on the drug. Labels warn about pulmonary aspiration during anesthesia or deep sedation because gastric emptying is slowed. Stopping or continuing around an operation is the surgeons’ and the prescriber’s decision together.

How the setting changes the bill

A clinic may bill an office visit to insurance and send the prescription to a retail pharmacy, where your plan or a manufacturer offer takes over. A telehealth company may charge a cash visit fee or a subscription and route the prescription to a mail pharmacy. Those are different invoices. Add them before you compare “$349 a month” with “$149 a month.” One of those ads may be the drug. The other may be the drug plus the visit, or the visit alone, or a compounded product. Savings offers and cash prices separate the drug figures that manufacturers actually published.

Ask who you call on a Sunday if you cannot keep fluids down. If the answer is an emergency department, that is an honest answer for severe symptoms and a poor answer for moderate nausea that a prescriber should hear on Monday. Ask how to get records sent to your primary-care clinician. Fragmented care is how two GLP-1 prescriptions get filled at once.

A short comparison you can fill in

Question Office or specialist Video service
Clinician name and license
Starting dose matches the label
Follow-up is a person, not only a refill
Product is approved or compounded
Visit fee, drug price, and shipping, listed apart
Records can be sent to your other clinicians

Licensure is worth one more check you can do without the clinic’s help. State medical-board sites let you look up a name. If the service will not give you a name before you pay a nonrefundable fee, you cannot do that check. A clinic policy that assigns “the next available clinician” can still be legitimate if the name appears on the visit summary and that person is licensed in your state. Ask for the summary. If follow-up messages come from a coach who cannot prescribe, ask how a dose change actually gets signed. Coaches can help with food logs. They cannot legally be the prescriber by a different job title.

If a box stays empty, you do not have a comparison yet. You have a homepage. The prescription guide is the longer list of clinical questions to ask once a person is actually on the call.

Sources checked for this sheet

  1. https://www.yalemedicine.org/news/glp-1-medications-for-weight-loss-how-to-get-started
  2. https://utswmed.org/medblog/glp1-frequently-asked-questions/
  3. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  4. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s041lbl.pdf
  5. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity
  6. https://www.fda.gov/news-events/press-announcements/fda-warns-30-telehealth-companies-against-illegal-marketing-compounded-glp-1s
  7. https://glp1.here/guides/get-glp-1-online
  8. https://bestonlineglp1program.com/